Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 11, 2010, Pages 995-1005

  Master, Adam ^a   Wójcicka, Anna ^a   Piekiełko Witkowska, Agnieszka ^a   Bogusławska, Joanna ^a   Popławski, Piotr ^a   Tański, Zbigniew ^b   Darras, Veerle M ^c   Williams, Graham R ^d   Nauman, Alicja ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b Regional Hospital Ostroleka   (Poland)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CcRCC; MiRNA; Renal cancer; Thyroid hormone; Thyroid hormone receptor beta 1; Translational control in cancer; Untranslated region

Indexed keywords

LIOTHYRONINE; MESSENGER RNA; MICRORNA; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA1; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRESS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; UNTRANSLATED REGION;

5' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IODIDE PEROXIDASE; KIDNEY; KIDNEY NEOPLASMS; MICRORNAS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID HORMONE RECEPTORS BETA; TRIIODOTHYRONINE; UNTRANSLATED REGIONS;

EID: 77956647721     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.07.025     Document Type: Article

References (54)

1. Bassett J.H., Harvey C.B., Williams G.R. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell. Endocrinol. 2003, 213:1-11.
2. Qi J.S., Yuan Y., Desai-Yajnik V., Samuels H.H. Regulation of the mdm2 oncogene by thyroid hormone receptor. Mol. Cell. Biol. 1999, 19:864-872.
3. Dinda S., Sanchez A., Moudgil V. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 2002, 21:761-768.
4. Puzianowska-Kuznicka M., Nauman A., Madej A., Tanski Z., Cheng S., Nauman J. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett. 2000, 155:145-152.
5. Li Z., Meng Z.H., Chandrasekaran R., Kuo W.L., Collins C.C., Gray J.W., Dairkee S.H. Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer. Cancer Res. 2002, 62:1939-1943.
6. Kamiya Y., Puzianowska Test M. Expression of mutant thyroid hormone nuclear receptors is associated with human renal cell carcinoma. Carcinogenesis 2002, 23:25-33.
7. Myasnikov A.G., Simonetti A., Marzi S., Klaholz B.P. Structure-function insights into prokaryotic and eukaryotic translation initiation. Curr. Opin. Struct. Biol. 2009, 19:300-309.
8. Chatterjee S., Pal J.K. Role of 5'- and 3'-untranslated regions of mRNAs in human diseases. Biol. Cell. 2009, 101:251-262.
9. Mannavola D., Moeller L.C., Beck-Peccoz P., Persani L., Weiss R.E., Refetoff S. A novel splice variant involving the 5' untranslated region of thyroid hormone receptor beta1 (TRbeta1). J. Endocrinol. Invest. 2004, 27:318-322.
10. Frankton S., Harvey C.B., Gleason L.M., Fadel A., Williams G.R. Multiple messenger ribonucleic acid variants regulate cell-specific expression of human thyroid hormone receptor beta1. Mol. Endocrinol. 2004, 18:1631-1642.
11. Mignone F., Gissi C., Liuni S., Pesole G. Untranslated regions of mRNAs. Genome Biol. 2002, 3(3). (REVIEWS0004).
12. Sobczak K., Krzyzosiak W.J. Structural determinants of BRCA1 translation regulation. J. Biol. Chem. 2002, 277:17349-17358.
13. Chen L.I., Sommer K.M., Swisshelm K. Downstream codons in the retinoic acid receptor beta-2 and beta-4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription. J. Biol. Chem. 2002, 277:35411-35421.
14. Peng X., Mehta R.G., Tonetti D.A., Christov K. Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells. Oncogene 2005, 24:1296-1301.
15. Grignon D.J., Che M. Clear cell renal cell carcinoma. Clin. Lab. Med. 2005, 25:305-316.
16. Peltier H.J., Latham G.J. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008, 14:844-852.
17. Reyns G.E., Venken K., Morreale de Escobar G., Kühn E.R., Darras V.M. Dynamics and regulation of intracellular thyroid hormone concentrations in embryonic chicken liver, kidney, brain, and blood. Gen. Comp. Endocrinol. 2003, 134:80-87.
18. Mathews D.H., Disney M.D., Childs J.L., Schroeder S.J., Zuker M., Turner D.H. Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7287-7292.
19. Brunak S., Engelbrecht J., Knudsen S. Prediction of Human mRNA Donor and Acceptor Sites from the DNA Sequence. J. Mol. Biol. 1991, 220:49-65.
20. Reese M.G., Eeckman F.H., Kulp D., Haussler D. Improved splice site detection in gene. J. Comput. Biol. 1997, 4:311-323.
21. Rehmsmeier M., Steffen P., Hochsmann M., Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517.
22. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., de Piedade I., Gunsalus K.C., Stoffel M., Rajewski N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
23. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
24. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
25. Toyoda N., Zavacki A.M., Maia A.L., Harney J.W., Larsen P.R. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol. Cell. Biol. 1995, 15:5100-5112.
26. Amma L.L., Campos-Barros A., Wang Z., Vennström B., Forrest D. Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Mol. Endocrinol. 2001, 15:467-475.
27. Bianco A.C., Salvatore D., Gereben B., Berry M.J., Larsen P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 2002, 23:38-89.
28. Puzianowska-Kuznicka M., Nauman A., Madej A., Tanski Z., Cheng S., Nauman J. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett. 2000, 155:145-152.
29. Pachucki J., Ambroziak M., Tanski Z., Luczak J., Nauman J., Nauman A. Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. J. Endocrinol. Invest. 2001, 24:253-261.
30. Piekielko-Witkowska A., Master A., Wojcicka A., Boguslawska J., Brozda I., Tanski Z., Nauman A. Disturbed expression of type 1 iodothyronine deiodinase splice variants in human renal cancer. Thyroid 2009, 19:1105-1113.
31. Bates D.O., Cui T.G., Doughty J.M., Winkler M., Sugiono M., Shields J.D., Peat D., Gillatt D., Harper S.J. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 2002, 62:4123-4131.
32. Tsuji E., Tsuji Y., Fujiwara T., Ogata S., Tsukamoto K., Saku K. Splicing variant of Cdc42 interacting protein-4 disrupts beta-catenin-mediated cell-cell adhesion: expression and function in renal cell carcinoma. Biochem. Biophys. Res. Commun. 2006, 339:1083-1088.
33. Mahotka C., Krieg T., Krieg A., Wenzel M., Suschek C.V., Heydthausen M., Gabbert H.E., Gerharz C.D. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int. J. Cancer. 2002, 100:30-36.
34. Willis A.E. Translational control of growth factor and proto-oncogen expression. Int. J. Biochem. Cell. Biol. 1999, 31:73-86.
35. De Benedetti A., Graff J.R. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004, 23:3189-3199.
36. Frost G.I., Mohapatra G., Wong T.M., Csóka A.B., Gray J.W., Stern R. HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene 2000, 19:870-877.
37. Wang X.-Q., Rothnagel J.A. Post-transcriptional regulation of the GLI1 oncogene by the expression of alternative 50 untranslated regions. J. Biol. Chem. 2001, 276:1311-1316.
38. Findlay V.J., Turner D.P., Moussa O., Watson D.K. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 2008, 68:8499-8506.
39. Martínez-Iglesias O., Garcia-Silva S., Regadera J., Aranda A. Hypothyroidism Enhances Tumor Invasiveness and Metastasis Development. PLoS ONE 2009, 4:e6428.
40. Martínez-Iglesias O., Garcia-Silva S., Tenbaum S.P., Regadera J., Larcher F., Paramio J.M., Vennström B., Aranda A. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res. 2009, 69:501-509.
41. Zhu X.G., Zhao L., Willingham M.C., Cheng S.Y. Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene 2010, 29:1909-1910.
42. López-Fontal R., Zeini M., Través P.G., Gómez-Ferrería M., Aranda A., Sáez G.T., Cerdá C., Martín-Sanz P., Hortelano S., Boscá L. Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy. PLoS One 2010, 5:e8710.
43. Nauman P., Bonicki W., Michalik R., Warzecha A., Czernicki Z. The concentration of thyroid hormones and activities of iodothyronine deiodinases are altered in human brain gliomas. Folia Neuropathol. 2004, 42:67-73.
44. Nauman A., Nauman J., Pietrzykowski A., Lazecki D., Dutkiewicz S., Tanski Z., Witeska A., Kauczak M. The Low T3 Syndrome in patients with kidney cancer-the effect of cancer differentiation. Polish J. Endocrinol. 1996, 47:365-374.
45. Poplawski P., Nauman A. Thyroid hormone-triiodothyronine-has contrary effect on proliferation of human proximal tubules cell line (HK2) and renal cancer cell lines (Caki-2, Caki-1)-role of E2F4, E2F5 and p107, p130. Thyroid Res. 2008, 13:1:5.
46. Nygård M., Wahlström G.M., Gustafsson M.V., Tokumoto Y.M., Bondesson M. Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol. Endocrinol. 2003, 17:79-92.
47. Turowska O., Nauman A., Pietrzak M., Popβawski P., Master A., Nygard M., Bondesson M., Tanski Z., Puzianowska-Kuznicka M. Overexpression of E2F1 in clear cell renal cell carcinoma: a potential impact of erroneous regulation by thyroid hormone nuclear receptors. Thyroid 2007, 17:1039-1048.
48. Johnson D.G., Degregori J. Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Curr. Mol. Med. 2006, 6:731-738.
49. Liu Y.H., Lin C.Y., Lin W.C., Tang S.W., Lai M.K., Lin J.Y. Up-regulation of vascular endothelial growth factor-D expression in clear cell renal cell carcinoma by CD74: a critical role in cancer cell tumorigenesis. J. Immunol. 2008, 181:6584-6594.
50. Furuya F., Lu C., Guigon C.J., Cheng S.Y. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids 2009, 74:628-634.
51. Chen M., Ye Y., Yang H., Tamboli P., Matin S., Tannir N.M., Wood C.G., Gu J., Wu X. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int. J. Cancer. 2009, 125:2342-2348.
52. Rosen M.D., Privalsky Thyroid M.L. hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity. Mol. Endocrinol. 2009, 23:1183-1192.
53. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method. Methods 2001, 25:402-408.
54. Kuiper G.G., Wassen F., Klootwijk W., Van Toor H., Kaptein E., Visser T.J. Molecular basis for the substrate selectivity of cat type I iodothyronine deiodinase. Endocrinology 2003, 144:5411-5421.